Insider Transactions in Q4 2025 at Summit Therapeutics Inc. (SMMT)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 21
2025
|
Yu Xia Director |
BUY
Open market or private purchase
|
Indirect |
533,617
+1.64%
|
$9,605,106
$18.74 P/Share
|
|
Oct 21
2025
|
Manmeet Singh Soni COO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
53,361
+1.71%
|
$960,498
$18.74 P/Share
|
|
Oct 21
2025
|
Bhaskar Anand Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,680
+14.31%
|
$480,240
$18.74 P/Share
|
|
Oct 21
2025
|
Maky Zanganeh Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
14,247,597
+1.71%
|
$256,456,746
$18.74 P/Share
|
|
Oct 21
2025
|
Maky Zanganeh Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
26,680
+25.81%
|
$480,240
$18.74 P/Share
|
|
Oct 21
2025
|
Robert W Duggan Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
26,680
+25.81%
|
$480,240
$18.74 P/Share
|
|
Oct 21
2025
|
Robert W Duggan Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
266,808
+1.03%
|
$4,802,544
$18.74 P/Share
|
|
Oct 21
2025
|
Robert W Duggan Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,980,789
+2.39%
|
$251,654,202
$18.74 P/Share
|